Cinnamomum bejolghota var. bejolghota
Cinnamomum bejolghota var. bejolghota · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cinnamomum bejolghota var. bejolghota is a significant botanical species known for its diverse medicinal properties and aromatic qualities. This plant is highly valued in traditional wellness practices due to the potent bioactive compounds found within its tissues. Various preparations, including specialized plant extracts, are utilized to harness its therapeutic potential for health applications. By isolating these essential components, researchers and practitioners can create concentrated forms for more effective use. Understanding the chemistry of these extracts is crucial for maximizing the plant's biological benefits.
- Synonyms
- Laurus Bazania · Laurus Bezolghota · 6 more
- Common names
- Not available
- Family
- Lauraceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Synonyms
Cinnamomum bejolghota var. bejolghota is a complex taxon that is recognized by several different botanical synonyms. It has been historically identified in scientific literature as Cinnamomum bazania and Cinnamomum obtusifolium. Furthermore, this variety shares nomenclature with specific subspecies such as Cinnamomum obtusifolium var. sikkimense and Cinnamomum obtusifolium var. vanhouttei. The plant is also linked to the name Cinnamomum soncaurium within various taxonomic frameworks. Understanding these overlapping identities is essential for accurate botanical classification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Cinnamomum bejolghota var. bejolghota is a distinct botanical specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida, reflecting its fundamental structural characteristics. The plant is further organized into the order Laurales, a group that highlights its evolutionary lineage. It is a prominent member of the genus Cinnamomum, which is widely recognized for its aromatic properties. Finally, this variety is nested within the Lauraceae family, solidifying its place in the complex hierarchy of the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Laurales |
| Family | Lauraceae |
| Genus | Cinnamomum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cinnamomum bejolghota var. bejolghota exhibits a diverse geographical range that spans both temperate and tropical regions of Asia. Within the temperate zones, this variety is notably distributed across various parts of China, including the South-Central and Southeast regions, as well as the island of Hainan. Its presence extends into tropical climates as well, where it flourishes throughout the Indian Subcontinent. Specifically, populations can be identified in the lush landscapes of Assam and across Bangladesh. This wide-reaching distribution highlights the plant's adaptability to different ecological niches across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Conditions
Cinnamomum bejolghota var. bejolghota acts as a therapeutic agent in the treatment of triple-negative breast cancer (TNBC). This plant extract shows promise in addressing the aggressive nature of this specific cancer subgroup. Specifically, it functions by treating the phosphorylation of p65, a process closely linked to resistance mechanisms in cancer cells. By targeting this pathway, the plant helps overcome cellular defenses that limit the efficacy of certain treatments. These targeted actions highlight its potential role in managing TNBC through specialized biochemical intervention.
Preparations
Cinnamomum bejolghota var. bejolghota is prepared as plant extracts to investigate potential therapeutic applications in cancer treatment. These specific extracts are utilized to study their ability to sensitize breast cancer cells to TRAIL. By testing various medicinal plant formulations, researchers can identify synergistic effects that help overcome resistance mechanisms. The preparation of such extracts serves as a critical step in developing effective combination therapies for triple-negative breast cancer. Consequently, these plant extracts represent a promising avenue for improving clinical outcomes through targeted biological interventions.